Correlation Between Cyclacel Pharmaceuticals and Arrayit
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Arrayit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Arrayit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Arrayit, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Arrayit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Arrayit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Arrayit.
Diversification Opportunities for Cyclacel Pharmaceuticals and Arrayit
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cyclacel and Arrayit is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Arrayit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrayit and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Arrayit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrayit has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Arrayit go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and Arrayit
If you would invest 42.00 in Cyclacel Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of 4.00 from holding Cyclacel Pharmaceuticals or generate 9.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 97.62% |
Values | Daily Returns |
Cyclacel Pharmaceuticals vs. Arrayit
Performance |
Timeline |
Cyclacel Pharmaceuticals |
Arrayit |
Cyclacel Pharmaceuticals and Arrayit Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyclacel Pharmaceuticals and Arrayit
The main advantage of trading using opposite Cyclacel Pharmaceuticals and Arrayit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Arrayit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrayit will offset losses from the drop in Arrayit's long position.Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings | Cyclacel Pharmaceuticals vs. Edgewise Therapeutics |
Arrayit vs. JD Sports Fashion | Arrayit vs. Sphere Entertainment Co | Arrayit vs. BRP Inc | Arrayit vs. Valhi Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |